Dra. María Eugenia Jiménez Corona
Deputy General Director of Epidemiology · Directorate General of Epidemiology (DGE)
Dra. María Eugenia Jiménez Corona serves as Deputy General Director of Epidemiology, Secretary of Health.
Vaccination COVID-19 Organization Analysis Fund Raising Immunology
Prof. Antonio Torres
Full Professor of Medicine, Head of Respiratory Intensive Care Unit · Hospital Clinic de Barcelona
Torres is Full Professor in Medicine at the University of Barcelona (UB) and Head of the Respiratory Intesive Care Unit at Hospital Clínic
Coronavirus Acute Respiratory Distress Syndrome (ARDS-ALI) Immunocompromised Patients Chronic Obstructive Pulmonary Disease (COPD) Lung Infections
Prof. Elias Mossialos
Professor of Health Policy · Department of Social Policy, London School of Economics
Professor Mossialos's research interests are health systems and policy, with a specific focus on the impact of EU law on health care systems
Long Term Care European Health Policy Comparative Health Policy Funding Health Care Health Services Research
Dennis Wright, Ph.D.
Professor of Medicinal Chemistry · University of Connecticut
Prof. Dennis Wright is an expert in medicinal pharmacy, therapeutic development for infectious disease and cancer.
Drug Design Infectious Disease Cancer Medicinal Chemistry
Dr. Sima Salahshor
Principal, Shiruy, Inc · Adjunct Professor, University of Toronto
Health Innovation Advisory and Program Design & Management
Program and Project Management Marketing & Corporate Strategy Medical Guideline and Policy Business Development & Partnerships Health Technologies
Margaret "Peg" Riley
Professor of Biology · University of Massachusetts Amherst
The focus of Peg Riley's research is in the area of microbial evolution - namely antimicrobial resistance evolution - and drug development.
Evolution of microbial resistance Alternatives to antibiotics Drug Discovery Antimicrobial Drug Discovery Antibiotic Resistance
Chip Schooley
Infectious Disease Specialist · UC San Diego
Dr. Chip Schooley's personal research interests include HCV, influenza and HIV pathogenesis.
COVID-19 Tropical Medicine HIV & AIDS Infectious Diseases Clinical Trials
Dr Kristen Reyher
Reader in Veterinary Epidemiology and Population Health · University of Bristol
Addressing One Health challenges - antimicrobial resistance and veterinary-farmer communication
Antimicrobial Stewardship Farm Vets Vet Communications Livestock Veterinary Epidemiology
Barry Elkind
Manager, Technology & Venture Development (Head, Molecular Diagnostics) · MaRS Innovation
Commercializing life science technologies in the areas of molecular diagnostics, medical devices and therapeutics
Molecular Cell Biology Molecular Diagnostics Life Sciences Commercialization Project and Program Management
Paul Beringer, PharmD
Chair & Professor of the Titus Family Department of Clinical Pharmacy · USC School of Pharmacy
Paul Beringer is an expert in the area of cystic fibrosis pharmacotherapy.
Host Defense Peptides Pharmacokinetics and Pharmacodynamics Cystic Fibrosis Antimicrobial and Anti-inflammatory Therapies
Ramani Varanasi
President and CEO · X-Biotix Therapeutics
Ramani Varanasi is a biopharmaceutical expert with experience structuring, negotiating and executing successful strategic alliances.
Clinical Trials Molecular Biology Oncology Pharmaceutical Industry Biotechnology
Dr. Maria De Lourdes Garcia-Garcia
Deputy Director · Centre for Research on Infectious Disease (Instituto Nacional de Salud Publica)
Dr. Garcia-Garcia has been interested in research in infectious diseases particularly tuberculosis and vaccine preventable diseases
Vaccination Adult Vaccination Infectious Diseases Influenza Tuberculosis
Irving Steinberg, PharmD
Associate Dean for Faculty Affairs & Associate Professor of Clinical Pharmacy and Pediatrics · USC School of Pharmacy
Areas of research emphasis include predictive performance of pharmacokinetic models for dosing in children.
COVID-19 Pediatric Pharmacotherapeutics Maternal-Fetal Pharmacology Infectious Diseases Critical Care Pharmacology and Toxicology